Financing
Boston Scientific·Cash Flow Statement·12 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from financing activities | $24M | $7M | $214M | $233M | -$340M | -$104M | -$184M | -$260M |
| Repayments of Short-Term Debt | — | — | — | $1.1B | $500M | $12M | $0 | $259M |
| Payment to net share settle employee equity awards | $2M | $3M | $4M | $118M | $5M | $5M | $3M | $85M |
| Proceeds from issuance of common stock relating to employee stock plans | $26M | $96M | $28M | $115M | $32M | $115M | $20M | $81M |
| Other, net | -$250K | -$250K | -$250K | -$10M | $9M | -$1M | $9M | $3M |
| Payment of Deferred Purchase Consideration | — | $97M | — | $0 | $62M | — | — | $3M |
| Noncontrolling interest transactions and other | -$250K | -$250K | -$250K | -$10M | $9M | -$1M | $9M | $3M |
| Noncontrolling Interests Activity and Other | -$250K | -$250K | -$250K | -$10M | $9M | -$1M | $9M | $3M |
| Finance Lease, Principal Payments | — | — | — | $36M | $6M | $7M | $209M | $0 |
| Proceeds From Issuance Of Senior Long Term Debt | — | — | — | $1.6B | — | — | — | $0 |
| Proceeds from (repayments of) short-term borrowings, net | $0 | $0 | $187M | -$192M | — | — | — | $0 |
| Finance lease prepayments | — | — | — | $36M | $6M | $7M | $209M | $0 |